What one share of Maravai LifeSciences Holdings holds
Maravai LifeSciences Holdings, Inc. (also referred to in this document as “Maravai,” “we,” “us,” “our” or “the Company”) is a life sciences company providing critical products and services to enable the development of drugs, therapeutics, vaccines, and diagnostics, and support research on human disease.
Maravai LifeSciences Holdings’s numbers from its SEC filings, divided by its shares. Results cover the last 12 months to 2026-06-30; the balance sheet is as of 2026-06-30.
| Sales | $1.43 |
|---|---|
| Profit | −$0.53 |
| Capex (buildings and equipment) | $0.07 |
| Free cash flow | −$0.25 |
| Cash and investments | $0.47 |
| Debt | $1.19 |
| Book value | $1.38 |
Per share by fiscal year
| Year | Sales | Profit | Capex | Free cash | Dividends | Book value |
|---|---|---|---|---|---|---|
| 2020 | $9.83 | $2.36 | $0.88 | $4.39 | — | — |
| 2021 | $3.10 | $1.56 | $0.06 | $1.37 | — | — |
| 2022 | $3.46 | $1.67 | $0.07 | $2.03 | — | $4.14 |
| 2023 | $2.19 | −$0.90 | $0.50 | $0.46 | — | $3.16 |
| 2024 | $1.88 | −$1.05 | $0.22 | −$0.16 | — | $2.36 |
| 2025 | $1.29 | −$0.91 | $0.09 | −$0.49 | — | $1.47 |
Common questions about Maravai LifeSciences Holdings
How much does one share of Maravai LifeSciences Holdings earn?
Over the last 12 months, Maravai LifeSciences Holdings lost $0.53 for each share on $1.43 of sales.
Does Maravai LifeSciences Holdings pay a dividend?
Maravai LifeSciences Holdings didn’t pay a dividend over the last 12 months, according to its SEC filings.
What is Maravai LifeSciences Holdings’s book value per share?
Maravai LifeSciences Holdings’s book value is $1.38 per share: what would be left for each share if it sold everything at the values on its books and paid every debt, as of June 30, 2026.
How much cash and debt does each share of Maravai LifeSciences Holdings have?
Each share of Maravai LifeSciences Holdings has $0.47 of cash and investments and $1.19 of debt, as of June 30, 2026.
What is Maravai LifeSciences Holdings’s free cash flow per share?
−$0.25 per share over the last 12 months. Free cash flow is the cash left over after spending on buildings and equipment.
Has Maravai LifeSciences Holdings bought back shares?
Maravai LifeSciences Holdings’s share count rose about 399% from 2020 to 2025. That dilution means each share owns a smaller slice of the company.
From its SEC filings. For education only, not investment advice. New to these words? See the StockSlicer glossary.